Food News and Research

RSS

FDA grants accelerated approval to NORTHERA (droxidopa) for patients with symptomatic NOH

Chelsea Therapeutics International, Ltd. today announced that the U.S. Food and Drug Administration granted accelerated approval of NORTHERA (droxidopa) for the treatment of symptomatic neurogenic orthostatic hypotension (NOH). NORTHERA is the first and only therapy approved by the FDA which demonstrates symptomatic benefit in patients with NOH.

18 Feb 2014

The Future of DNA Sequencing

In this interview, Barret Bready discusses the current gold standards in DNA sequencing and how the Nabsys platform is revolutionizing this process.

18 Feb 2014

First Edition: February 18, 2014

Kaiser Health News staff writer Jay Hancock, working in collaboration with USA Today, reports: "Congratulations. You bought insurance through one of the online Affordable Care Act exchanges, possibly after days or weeks of trying to get the site to work. Don't relax. Joining the plan is only the first challenge. Now you have to understand it. Policies sold through the online portals -- to more than 3 million people so far -- cover essential benefits and put a cap on your out-of-pocket medical costs. But you need to follow the rules" (Hancock, 2/17).

18 Feb 2014

Samoa Island harbors a global health mystery that could predict obesity crisis

The South Pacific archipelago of Samoa and American Samoa harbors a global health mystery that may seem both remote and extreme but could foretell trends in obesity and related conditions across much of the developing world.

18 Feb 2014

MAXIMUS Foundation distributes grants to 87 local non-profit organizations

MAXIMUS, a leading provider of government services worldwide, announced today that the MAXIMUS Foundation has distributed approximately $206,000 in grants to 87 local non-profit organizations as part of its most recent grant cycle.

18 Feb 2014

Upstream interventions may provide options to contain emerging pathogens at source

While many endemic infectious diseases of humans have been largely contained, new microbes continue to emerge to threaten human and animal health.

18 Feb 2014

GENFIT receives FDA Fast Track designation for GFT505 development program in NASH

GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces that the Food and Drug Administration has granted Fast Track designation to the GFT505 development program in NASH, with effect from February 14, 2014.

18 Feb 2014

Sports medicine experts raise concern about female athlete triad syndrome

When an adolescent female patient comes to Nationwide Children's Hospital's Sports Medicine clinic, not only are these young women treated for their sports-related injury, but their sports medicine physician will also ask if they've missed any periods, because of a growing concern among female athletes.

18 Feb 2014

Heartier appetite linked to more rapid infant growth, weight gain

A heartier appetite is linked to more rapid infant growth and to genetic predisposition to obesity, according to two papers published in JAMA Pediatrics today (Monday).

18 Feb 2014

Study provides comprehensive analysis of the evolutionary relationships of influenza virus

A new study reconstructing the evolutionary tree of flu viruses challenges conventional wisdom and solves some of the mysteries surrounding flu outbreaks of historical significance.

17 Feb 2014

Resolution of inflammation is altered in Alzheimer's disease

New research from Karolinska Institutet in Sweden shows that the final stage of the normal inflammatory process may be disrupted in patients with Alzheimer's disease.

17 Feb 2014

Forest Laboratories plans to discontinue sale of NAMENDA 5 mg and 10 mg tablets

Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, today announced that it plans to discontinue the sale of NAMENDA (memantine HCl) 5 mg and 10 mg tablets effective August 15, 2014.

16 Feb 2014

University of Adelaide research reveals new approach for bowel cancer treatment

University of Adelaide research has shown for the first time that grape seed can aid the effectiveness of chemotherapy in killing colon cancer cells as well as reducing the chemotherapy's side effects.

16 Feb 2014

People in northern latitudes have greater proportion of obesity-related bacteria in gut

People living in cold, northern latitudes have bacteria in their guts that may predispose them to obesity, according to a new study by researchers at the University of California, Berkeley, and the University of Arizona, Tucson.

15 Feb 2014

Attention modification programs help decrease overeating in obese children

Among the multiple factors that can cause obesity is an abnormal neurocognitive or behavioral response to food cues. The brain becomes wired to seek - and expect - greater rewards from food, which leads to unhealthful overeating.

15 Feb 2014

Final stage of normal inflammatory process may be disrupted in patients with Alzheimer's disease

New research from Karolinska Institutet in Sweden shows that the final stage of the normal inflammatory process may be disrupted in patients with Alzheimer's disease. A study published in the journal Alzheimer's & Dementia shows that levels in the brain and cerebrospinal fluid of the molecules necessary for tissue recovery through the clearance of harmful inflammatory substances are lower than normal in patients with Alzheimer's disease. The study also showed association between the lower levels of these molecules with impaired memory function.

14 Feb 2014

FDA approves IMRIS’ VISIUS Surgical Theatre that integrates high-field MR scanners

IMRIS Inc. today announced US Food and Drug Administration clearance of the newest generation VISIUS® Surgical Theatre which integrates Siemens' latest high-field MR scanners.

14 Feb 2014

Researchers develop new model for isolating effects of nutrients on gene expression, physiology

Everyday our cells take in nutrients from food and convert them into the building blocks that make life possible. However, it has been challenging to pinpoint exactly how a single nutrient or vitamin changes gene expression and physiology.

14 Feb 2014

FDA approves Biologics’ IMBRUVICA as oral agent for treatment of patients with CLL

Biologics, a limited distribution network partner for IMBRUVICA™ (ibrutinib), is pleased to announce the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules as a single, oral agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

14 Feb 2014

Longer looks: Women's advantages in health law; health effects of the 'American Dream'

Every week reporter Ankita Rao selects interesting reading from around the Web.

14 Feb 2014

Food News and Research

FDA grants accelerated approval to NORTHERA (droxidopa) for patients with symptomatic NOH

The Future of DNA Sequencing

First Edition: February 18, 2014

Samoa Island harbors a global health mystery that could predict obesity crisis

MAXIMUS Foundation distributes grants to 87 local non-profit organizations

Upstream interventions may provide options to contain emerging pathogens at source

GENFIT receives FDA Fast Track designation for GFT505 development program in NASH

Sports medicine experts raise concern about female athlete triad syndrome

Heartier appetite linked to more rapid infant growth, weight gain

Study provides comprehensive analysis of the evolutionary relationships of influenza virus

Resolution of inflammation is altered in Alzheimer's disease

Forest Laboratories plans to discontinue sale of NAMENDA 5 mg and 10 mg tablets

University of Adelaide research reveals new approach for bowel cancer treatment

People in northern latitudes have greater proportion of obesity-related bacteria in gut

Attention modification programs help decrease overeating in obese children

Final stage of normal inflammatory process may be disrupted in patients with Alzheimer's disease

FDA approves IMRIS’ VISIUS Surgical Theatre that integrates high-field MR scanners

Researchers develop new model for isolating effects of nutrients on gene expression, physiology

FDA approves Biologics’ IMBRUVICA as oral agent for treatment of patients with CLL

Longer looks: Women's advantages in health law; health effects of the 'American Dream'

Understanding cultivated meat and its global potential eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News